CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 31, 2017--
Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage
biopharmaceutical company focusing on the development of next-generation
therapeutics for the treatment of complement-mediated diseases, today
announced that Doug Treco, Ph.D., President and Chief Executive Officer,
will present at the following upcoming investor conferences:
The Credit Suisse 26th Annual Healthcare Conference on Tuesday,
November 7, 2017 at 9:10 a.m. M.T. The conference is being held at the
Phoenician Resort in Scottsdale, AZ.
The Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017 at
4:15 p.m. E.T. The conference is being held at the Lotte New York
The Jefferies Global Healthcare Conference on Thursday, November 16,
2017 at 2:00 p.m. G.M.T.
Live webcasts of each presentation can be accessed by visiting the
investor relations section of the Company’s website, www.rapharma.com.
A replay of the presentations will also be available and archived on the
site for three weeks following each presentation.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company
focusing on the development of next-generation therapeutics for
complement-mediated diseases. The Company discovers and develops
peptides and small molecules to target key components of the complement
cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171031005349/en/
Source: Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc.
Eliza Schleifstein, 917-763-8106